Imunon, Inc. Depreciation
Imunon, Inc. (IMNN) reported Depreciation of $140.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-11
- Imunon, Inc. depreciation for the quarter ending 2026-06-30 was $70.00K, a 6.68% decline year-over-year.
- Imunon, Inc. depreciation for the quarter ending 2026-03-31 was $70.00K, a 4.98% increase year-over-year.
- Imunon, Inc. depreciation for the quarter ending 2025-12-31 was $75.08K, a 101.62% increase year-over-year.
- Imunon, Inc. depreciation for the quarter ending 2025-09-30 was $75.14K, a 16.85% increase year-over-year.
- Imunon, Inc. depreciation for fiscal 2025 was $291.91K, a 21.54% increase from fiscal 2024.
- Imunon, Inc. depreciation for fiscal 2024 was $240.18K, a 3.22% decline from fiscal 2023.
- Imunon, Inc. depreciation for fiscal 2023 was $248.15K, a 26.28% increase from fiscal 2022.
- Imunon, Inc. depreciation for fiscal 2022 was $196.51K, a 51.16% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $70.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $140.00K 10-Q · filed 2026-08-11 | $215.08K derived: sum of 3 quarters · filed 2026-08-11 | $290.22K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $70.00K 10-Q · filed 2026-05-12 | $145.08K derived: sum of 2 quarters · filed 2026-05-12 | $220.22K derived: sum of 3 quarters · filed 2026-05-12 | $295.23K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $75.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $150.22K derived: sum of 2 quarters · filed 2026-03-31 | $225.23K derived: sum of 3 quarters · filed 2026-08-11 | $291.91K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $75.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $150.15K derived: sum of 2 quarters · filed 2026-08-11 | $216.83K 10-Q · filed 2025-11-13 | $254.07K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $75.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $141.69K 10-Q · filed 2026-08-11 | $178.93K derived: sum of 3 quarters · filed 2026-08-11 | $243.23K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $66.68K 10-Q · filed 2026-05-12 | $103.92K derived: sum of 2 quarters · filed 2026-05-12 | $168.22K derived: sum of 3 quarters · filed 2026-05-12 | $236.56K derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $37.24K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $101.54K derived: sum of 2 quarters · filed 2026-03-31 | $169.87K derived: sum of 3 quarters · filed 2026-03-31 | $240.18K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $64.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $132.64K derived: sum of 2 quarters · filed 2025-11-13 | $202.94K 10-Q · filed 2025-11-13 | $274.58K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $68.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $138.63K 10-Q · filed 2025-08-05 | $210.28K derived: sum of 3 quarters · filed 2025-08-05 | $278.31K derived: sum of 4 quarters · filed 2025-08-05 | |
| 2024-03-31 | $70.30K 10-Q · filed 2025-05-12 | $141.95K derived: sum of 2 quarters · filed 2025-05-12 | $209.97K derived: sum of 3 quarters · filed 2025-05-12 | $268.94K derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $71.64K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $139.67K derived: sum of 2 quarters · filed 2025-02-27 | $198.64K derived: sum of 3 quarters · filed 2025-02-27 | $248.15K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $68.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $127.00K derived: sum of 2 quarters · filed 2024-11-07 | $176.51K 10-Q · filed 2024-11-07 | $255.65K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $58.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $108.48K 10-Q · filed 2024-08-14 | $187.62K derived: sum of 3 quarters · filed 2024-08-14 | $223.62K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $49.51K 10-Q · filed 2024-05-13 | $128.65K derived: sum of 2 quarters · filed 2024-05-13 | $164.65K derived: sum of 3 quarters · filed 2024-05-13 | ||
| 2022-12-31 | $79.14K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $115.14K derived: sum of 2 quarters · filed 2024-03-28 | $196.51K 10-K · filed 2024-03-28 | $197.00K 10-K · filed 2023-03-30 | |
| 2022-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $117.37K 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | $81.37K 10-Q · filed 2023-08-10 | ||||
| 2021-12-31 | $130.00K 10-K · filed 2023-03-30 | ||||
| 2020-12-31 | $130.00K 10-K · filed 2022-03-31 | ||||
| 2019-12-31 | $128.50K 10-K · filed 2021-03-19 | ||||
| 2018-12-31 | $130.00K 10-K · filed 2020-03-25 | ||||
| 2017-12-31 | $326.00K 10-K · filed 2019-03-29 | ||||
| 2016-12-31 | $455.00K 10-K · filed 2018-03-27 | ||||
| 2015-12-31 | $425.00K 10-K · filed 2017-03-24 | ||||
| 2014-12-31 | $369.00K 10-K · filed 2016-03-30 | ||||
| 2013-12-31 | $339.00K 10-K · filed 2016-03-30 | ||||
| 2012-12-31 | $281.50K 10-K · filed 2015-03-12 | ||||
| 2011-12-31 | $169.00K 10-K · filed 2014-03-13 | ||||
| 2010-12-31 | $165.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |